Radiation Oncology/Bile duct/Clinical Trials

Link to Cancer.gov biliary tract cancer trials. Protocol ID below is cross-linked to the appropriate cancer.gov page.

Chemotherapy

Phase	Protocol ID	Protocol Name
Phase III	XL119-001	XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects with Advanced Biliary Tumors
Phase II	SWS-SAKK-44/02	Phase II Study of Adjuvant Palliative Capecitabine and Gemcitabine in Patients With Locally Advanced or Metastatic Biliary Tract Cancer
Phase II	NYWCCC-0803945	Phase II Study of 3-AP (Triapine®) and Gemcitabine in Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer
Phase II	FCCC-03042	Phase II Study of Bortezomib as First-Line Systemic Therapy in Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Phase II	NCI-04-C-0273	Phase II Study of Intrahepatic Arterial Infusion of Melphalan With Venous Filtration Via Peripheral Hepatic Perfusion in Patients With Unresectable Primary or Metastatic Liver Cancer
Phase II	UTMB-NCI-931	Phase II Randomized Study of Immunization With Carcinoembryonic Antigen (CEA) Peptide 1-6D Emulsified in Montanide ISA-51 Versus Dissolved in Sargramostim (GM-CSF) in HLA-A2+ Patients With CEA-Producing Adenocarcinomas of Gastrointestinal Tract Origin
Phase I/II	NCCTG-N9943	Phase I/II Study of Gemcitabine and Pemetrexed Disodium in Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer